Hookipa Pharma
Price & Volume
Stats
See moreOpen | $4.63 |
Previous Close | $4.72 |
Day Range | $4.61-$4.73 |
52W Range | $4.10-$11.30 |
Market Cap | $46.2M |
Shares Short | 24,231 |
Financials
See moreRevenue (12 Mos) | $52.1M |
Revenue Growth (YoY) | -51.8% |
Gross Profit (12 Mos) | -$52.9M |
Diluted EPS | -$4.12 |
News
See moreYahoo Finance • 10 months ago
HOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-500 for the Treatment of Human Immunodeficiency Virus
Yahoo Finance • 10 months ago
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Yahoo Finance • 11 months ago
HOOKIPA Pharma Presents Positive Biomarker and Translational Data on HB-200 Monotherapy at Society for Immunotherapy of Cancer 2023
Yahoo Finance • 11 months ago
HOOKIPA Pharma to Report Third Quarter 2023 Financial Results and Recent Business Highlights on November 9, 2023
About
CEO | Dr. Malte Peters M.D. |
CFO | Ms. Mary Theresa Coelho M.B.A. |
Address | 350 Fifth Avenue, New York, NY, United States, 10118 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 151 |
